Last reviewed · How we verify
Hepatitis A — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Vaccine Support Cp | Vaccine administration | Women and Infants Hospital of Rhode Island | vaccine | unknown | ||
| Hospital-Based Vaccination Pathway | hospital-based-vaccination-pathway | Pfizer | vaccine | various pathogens |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Hepatitis A
- Women and Infants Hospital of Rhode Island · 1 drug in Hepatitis A
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Hepatitis A:
- Hepatitis A treatment updates — RSS
- Hepatitis A treatment updates — Atom
- Hepatitis A treatment updates — JSON
Cite this brief
Drug Landscape (2026). Hepatitis A — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hepatitis-a. Accessed 2026-06-10.
Related
- Hepatitis A full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing